Activated Charcoal Aesculus Hippocastanum Bark Ant

證據等級: L5

預測適應症: 0 個

Multi-Ingredient Botanical Formula: TxGNN Prediction Not Available

One-Sentence Summary

This Evidence Pack describes a complex 25-ingredient botanical/homeopathic formula that is not currently marketed in the United States and has no DrugBank ID assigned to the multi-ingredient combination. The TxGNN model was unable to generate any repurposing prediction for this formula — most likely because the combination product cannot be mapped to a single node in the DrugBank knowledge graph. Without a valid prediction and without any registered indication, this candidate cannot proceed to formal repurposing evaluation at this time.

Quick Overview

Item	Content
Original Indication	Not established — no US licenses found
Predicted New Indication	No prediction available
TxGNN Prediction Score	N/A
Evidence Level	L5 (model prediction only) — in practice, no prediction was generated
US Market Status	Not marketed (0 NDAs)
Number of NDAs	0
Recommended Decision	Hold

Why No Prediction Was Generated

The queried drug string consists of 25 distinct botanical and chemical ingredients, including:

Classical hepatic/lymphatic herbs: Cynara scolymus (artichoke), Taraxacum palustre (dandelion), Arctium lappa (burdock), Berberis vulgaris (barberry)
Venous/circulatory botanicals: Aesculus hippocastanum (horse chestnut), Hamamelis virginiana (witch hazel), Vitis vinifera (grape)
Mineral/chemical components: Activated charcoal, Antimony trisulfide, Silver nitrate, Cholesterol
Traditional herbal tonics: Ginkgo, Goldenseal (Hydrastis canadensis), Cinchona bark, Fucus vesiculosus (bladderwrack), Arnica montana

The TxGNN knowledge graph operates at the level of individual drug entities mapped to DrugBank IDs. Because:

No DrugBank ID exists for this multi-ingredient combination (drugbank_id: null)
Each constituent ingredient would require a separate DrugBank entry to be scored independently
The query returned zero prediction results (predicted_indications: [])

…the model was structurally unable to evaluate this formula. This is a data architecture gap, not a negative prediction.

The combination profile is consistent with homeopathic or naturopathic multi-botanical preparations (e.g., lymphatic drainage formulas, hepatic support products). Such proprietary blends are typically not assigned unified regulatory identifiers in standard pharmacological databases.

Safety Considerations

Please refer to the package insert for safety information.

Note on Silver Nitrate: One ingredient — Silver Nitrate — is a corrosive inorganic salt with known caustic properties. Even in homeopathic dilutions, its presence warrants attention in any future full safety assessment.

Conclusion and Next Steps

Decision: Hold

Rationale: The TxGNN pipeline cannot evaluate a 25-component formula without individual DrugBank node mappings, and the product has no established indication or US market authorization to anchor a repurposing analysis.

To proceed, the following is needed:

Decompose the formula — evaluate each of the 25 active ingredients individually through the TxGNN pipeline to identify which components may carry repurposing signal
Identify the lead ingredient(s) — determine which constituent(s) are pharmacologically active and have a DrugBank ID (e.g., Berberine from Berberis vulgaris, Quinine from Cinchona bark, Ginkgolides from Ginkgo)
Clarify product identity — confirm whether this is a licensed homeopathic product (OTC monograph), a dietary supplement, or an unlicensed compounded formula, as this determines the regulatory pathway
Retrieve original indication — obtain any historical or intended-use labeling to establish the repurposing baseline
Obtain MOA data — for key botanical actives with known pharmacology (e.g., Berberine: AMPK activation; Ginkgo: PAF inhibition; Horse chestnut: aescin / anti-edema)
Re-run TxGNN per-ingredient — submit each mappable ingredient separately to generate individual prediction scores, then aggregate
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.